Saturday, September 29, 2018

Bioequivalence & Bioavailability; Some Perspectives (MABB) - Juniper Publishers

Bioequivalence & Bioavailability; Some Perspectives in Juniper in Modern Applications of Bioequivalence & Bioavailability

The term “bioequivalence” refers to pharmaceutically equivalent products where the extent of bioavailability of the actives are not significantly (in the statistical sense) different under scientific conditions usually following the rules of scientific sampling. As a student of the famous W.E. Deming (1900-1993) these words are common knowledge to people and researchers like me. 





No comments:

Post a Comment

Retatrutide as a Novel Treatment for Obesity and Type 2 Diabetes- Juniper Publishers

  Diabetes & Obesity- Juniper Publishers Abstract Retatrutide is a triple hormone agonist of the receptors of glucagon-like peptide 1, g...